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INTRODUCTION 
Dacryocystitis is inflammation of the lacrimal sac usually 
secondary to obstruction of the nasolacrimal duct. The lacrimal drainage 
apparatus is an effective system for drainage of tears. When there is 
obstruction in the drainage apparatus, there is stasis of sac contents which 
forms a reservoir for development of infection. The close association of 
conjunctival and nasal mucosa with the sac makes it more prone to 
infection. The most common sources of infection are the nose, paranasal 
sinuses and pericystic tissues
1
.  
Dacryocysitis may be either congenital or acquired. Congenital 
dacryocystitis is usually due to incomplete canalisation of the 
nasolacrimal duct. Congenital blockage is seen in 3-6% of term infants
2
. 
Acquired dacryocystitis is commonly seen in middle age with the highest 
incidence noted in the 5th decade. Females (80%) are more commonly 
affected than males (20%). The increased incidence in females is due to 
the narrowness of the nasolacrimal duct. Dacryocysitis can be classified 
into two types - acute and chronic. Acute dacryocystitis  presents with 
pain, redness and tenderness over sac area. Chronic  dacryocystitis 
presents with persistent epiphora and regurgitation of mucoid or 
mucopurulent material on pressure over sac area. 
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AIM OF THE  STUDY 
 
1. To analyse the bacterial etiology in cases of chronic dacryocystitis  
reported at a tertiary level hospital. 
2. To assess the association of chronic dacryocystitis with age, sex of 
patient, duration of symptoms and laterality. 
3. To determine their invitro susceptibilities and resistance to 
antibiotics 
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REVIEW OF LITERATURE 
Anatomy of lacrimal apparatus 
Lacrimal gland 
The lacrimal gland is a tubuloacinar gland with short branched 
tubules lying above and anterolateral to the eyeball and secretes tears 
through a series of ducts into the superior fornix. The lacrimal gland is 
divided by the superior transverse ligament of Whitnall into         
 A large orbital or superior part 
 A small palpebral or inferior part in continuity with the superior part.                                                     
Ducts of lacrimal gland 
About 10-12 ducts pass downwards from the main gland and open 
into the lateral part of superior fornix
3
. Since all the ducts pass through 
the palpebral part of the gland, excision of the palpebral part alone 
amounts to excision of entire gland as far as secretory function of  the 
gland is concerned. 
Blood supply  
Main lacrimal gland is supplied by lacrimal artery, a branch of 
ophthalmic artery. Sometimes a branch of transverse facial artery may 
also supply the gland. Lacrimal veins draining the gland open into the 
ophthalmic vein. Lymphatic drainage is into preauricular nodes. 
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Nerve supply 
The sensory nerve supply to lacrimal gland is from the Lacrimal 
nerve,    a  branch  of ophthalmic  division of  the  fifth  cranial  nerve. 
The sympathetic  nerve supply comes from the carotid plexus of the 
cervical sympathetics. The para sympathetic secretomotor fibres arise 
from the superior salivatory nucleus; pass through the Greater superficial 
petrosal nerve which joins with the Deep petrosal nerve to form the Nerve 
of pterygoid canal (vidian nerve). From here para sympathetic fibres after 
relaying in the Spheno palatine ganglion pass via the Zygomatic nerve on 
to the Lacrimal nerve to reach the lacrimal gland.  
Accessory lacrimal glands 
The accessory glands of Krause and Wolfring are located in the 
superior fornix and above the superior border of tarsus respectively 
 Tear film composition  
 Mucinous or inner layer secreted by goblet cells 
 Aqueous or intermediate layer secreted by main and accessory 
lacrimal glands 
 Oily or outer layer secreted by meibomian glands                                                     
Lacrimal puncta 
Each punctum lacrimale is a small round oval orifice on the 
summit of an elevation, the papilla lacrimalis, near the medial end of the 
lid margin at the junction of the ciliated and non ciliated parts. The upper 
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punctum is slightly medial to the lower, their respective distances from 
the medial canthus being 6 and 6.5mm respectively
4
. The puncta are 
surrounded by a ring of dense fibrous tissue which keeps them patent. 
With each blink the puncta slide in the groove between the plica 
semilunaris and the eyeball. 
Lacrimal canaliculi 
The canaliculi are each 8-10 mm long. In 90% individuals they 
combine to form a common canaliculus that enters the lateral wall of the 
tear sac. A fold of mucosa, the valve of Rosenmuller, normally prevents 
tear reflux from the sac back into the canaliculi with operation of the tear 
pump. 
Lacrimal sac 
It lies in the lacrimal fossa located in the anterior part of medial 
orbital wall.  The fossa is bounded by the anterior and posterior lacrimal 
crests. Medial to the sac is the middle meatus of the nose and anterior 
ethmoidal cells separated by the thin lacrimal bone and the thicker frontal 
process of maxilla. The angular artery and vein lies 7-8 mm medial to the 
medial canthal angle. 
Nasolacrimal duct 
The nasolacrimal duct measures 12 mm in length and opens into 
the nose through an ostium that is usually partially covered by a mucosal 
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fold (valve of Hasner). The duct is directed downwards laterally and 
slightly posterior.  
Physiology of tear drainage 
Tear drainage is brought about  by an active lacrimal pump 
mechanism described by Rosengren-Doane
5
. It is constituted by fibres of 
the preseptal portion of the orbicularis which arise from the lacrimal 
fascia and the posterior lacrimal crest (Horner’s muscle). The contraction 
of the orbicularis muscle provides the motive force for drainage of tears. 
Conjunctival flora 
The conjunctiva and eyelids harbour many microorganisms which 
may be either resident flora or transient flora. Resident flora  comprises 
of Staphylococcus epidermidis and Corynebacterium xerosis. The 
transient flora is composed of both pathogenic and non pathogenic 
organisms.  
Normal conjunctival flora is held in check by the following factors 
 Flushing mechanism provided by tears 
 Bactericidal action of lysozymes present in tears 
 Phagocytosis of epithelial cells 
 Mechanical barrier of intact mucous membrane 
 Blinking action of lid 
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The various pathogens found in the conjunctiva are as follows  
Gram positive  
 Diphtheroids  
 Staphylococcus aureus 
 Hemolytic and Non hemolytic Streptococci 
 Bacillus species 
Gram negative 
 Hemophilus species 
 Moraxella species 
 Neisseria species 
Enteric species 
 Escherichia coli 
 Klebsiella pneumonia 
 Enterobacterium species 
Fungi  
 Aspergillus species 
 Mucor 
 Dematiaceous  fungi 
 Candida species 
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Evaluation of the nasolacrimal apparatus  
Examination with diffuse illumination using magnification: is 
done to rule out causes of reflex hypersecretion located in lids, 
conjunctiva, cornea etc. This should exclude punctal causes of epiphora 
and any swelling in sac area.  
Regurgitation test : a steady pressure is applied over lacrimal sac 
area. Reflux of mucopurulent discharge indicates chronic dacryocystitis 
with obstruction at lower end of nasolacrimal duct. 
Fluorescein dye disappearance test
6,7 : This is a physiologic test 
to analyse the lacrimal drainage which is useful in children and infants. 
The tears are stained with a moistened flourescein strip in each eye, 
patient is instructed not to wipe the eyes and blink at a normal rate and 
the tear film is observed after 5 minutes with cobalt blue filter of slit 
lamp. Persistence of dye and asymmetric clearance of dye from the 
conjunctival sac indicates a partial obstruction on the side retaining dye     
Jones I test
8
 : Fluorescein in the tears is recovered in the inferior 
meatus by passing a cotton tipped applicator into the region of opening of 
NLD after 2 and 5 minutes. Staining of the applicator indicates patency. 
Non staining indicates anatomic or physiologic block.  
          Jones II test : When Jones I test is negative, syringing is done in 
the same eye. Flourescein retrieved from the nose after syringing the 
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lacrimal sac indicates physiologic block. Absence of dye indicates 
anatomical block.  
Syringing :  Topical anesthetic is instilled and the lower punctum 
is dilated with Nettleship’s punctum dilator. Saline is injected through a 
smooth tipped cannula passed into the lacrimal canaliculus 2 mm 
downwards and then turned medially to lie in the horizontal portion of the 
canaliculus. Irrigating solution is injected and results are observed. If 
saline passes freely into the nose or throat it indicates patent nasolacrimal 
system. On syringing the block may be either complete, partial or 
functional. 
In complete NLD obstruction the fluid regurgitates through either 
the same punctum or the upper punctum depending on the level of 
obstruction.  
In partial NLD obstruction  there is a combination of saline reflux 
through upper punctum and the fluid passing into the patients throat.  
In functional block the saline passes freely into the nose or throat, 
as a patent nasolacrimal system is present. However this irrigation is 
successful under increased hydrostatic pressure  so there could still be a 
lacrimal  pump failure. 
          Probing : Diagnostic probing of the upper system confirms the 
level of obstruction. A lacrimal probe no.3.0 or 4.0 is used. If obstruction 
is encountered, the distance is measured by clamping the probe at the 
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punctum before withdrawal. The probe should not be forced through any 
area of resistance to avoid making a false passage. 
In canalicular block the resistance is felt at or before 8mm. Both 
canaliculi are tested separately. In common canalicular block the 
obstruction is at 8-10 mm
9
 and the probe meets a soft resistance (Soft 
stop) and on moving the probe against the resistance , the tissues at the 
medial canthus will be seen to move. In fibrosed small lacrimal sac or in 
nasolacrimal duct block, the probe meets a bony resistance beyond 10 
mm (hard stop) and on moving the probe against it, there is no movement 
of tissues at the medial canthus .   
Nasal endoscopy: is helpful in evaluation of nasal septal and 
turbinate diseases. It is now possible to directly visualise the nasal 
passages using endoscopic equipments. Presence of inferior turbinate 
hypertrophy or nasal polyps should be identified. 
Mini endoscope  known as dacryoscope allows direct visualisation 
of interior and lining of the lacrimal passages. 
Chemiluminescent evaluation : cyalume is injected with a 
sialography catheter to demonstrate the structure and patency of outflow 
passages. It eliminates any radiation exposure and may also be used 
during surgery. 
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Dacryocystography : is used to delineate the anatomy of lacrimal 
system, define level of obstruction
10
  and identify the presence of any 
fistula, diverticula, stone or tumour in the sac. To perform it, a radio-
opaque material such as lipiodol, dianosil or conray-280 is pushed into 
the sac using a lacrimal cannula. X rays are taken after 5 and 30 minutes 
to visualize the entire passage. For better anatomical visualization the 
modified technique known as ‘subtraction macrodacryocystography’ with 
canalicular catheterisation should be preferred. 
Scintigraphy
9
 : It requires radioactive dye, sodium pertechnate, 
instilled into the tear film. The lacrimal sac area is scanned with gamma 
camera to follow the progress of the dye into canaliculi, sac, NLD, and 
nose.  
CT : It is useful in craniofacial injuries, congenital craniofacial 
deformities or when neoplasia is suspected. It also helps in evaluating 
concomitant sinus or nasal diseases
11
.    
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Dacryocystitis 
Dacryocystitis is the inflammation of the lacrimal sac. The disease 
has been known from earliest times owing to its grosser manifestations 
involving abscesses and fistulae on the face but was interpreted variously 
and the general term, ήγνλοψ (argilops, a fistula) was given to all 
swellings of inner canthus. In the middle of first century A.D., Vesalius 
and Fallopius described the lacrimal system with considerable accuracy. 
Further George E. Stahl of Halle in 1702 described that the pathological 
manifestations of ήγνλοψ were due to inflammation, not of the tissues 
generally but of the naso-lacrimal canal, these manifestations taking three 
forms - acute, chronic and hydropsia or ulceration ( i.e., with a fistula).  
Duke elder remarked “Dacryocystitis - inflammation of lacrimal 
sac and duct – is a common and unpleasant disease, partly because of the 
troublesome and conspicuous symptoms it may cause, partly because it 
has little tendency to resolve and its adequate treatment presents 
considerable problems”. 
 It presents in three different forms : 
 Congenital dacryocystitis 
 Acute dacryocystitis 
 Chronic dacryocystitis 
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Congenital dacryocystitis 
Congenital dacryocystitis is seen in 3-6% of otherwise healthy 
infants. It is due to a failure of canalization of the duct so that its lumen is 
blocked near the lower ostium by epithelial debris, by a membrane or by 
a stricture in the bony canal. Of these the commonest cause is an 
imperforate membrane leading onto epiphora. In 80 to 90% of cases, the 
residual membrane spontaneously dissolves within 2 to 4 months after 
birth. Majority of persistent cases will respond to conservative treatment 
with antibiotics and lacrimal sac massage.     
Treatment includes 
 Proper counselling 
 Crigler’s massage – massage of the sac increases the hydrostatic 
pressure and may rupture the membranous obstruction. In large 
majority of cases, the cause of failure of conservative management is 
the improper technique of sac massage. It is therefore imperative to 
explain the proper way of massaging the sac area. The mother should 
be instructed to compress the sac by applying pressure with the pulp of 
the index finger and with firm, gentle pressure slide the finger down 
for about one inch in the groove between medial inferior orbital rim 
and nose. Ten strokes should be applied four times a day.    
 Topical antibiotics are reserved for cases with superadded bacterial 
conjunctivitis which is surprisingly uncommon. 
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 Probing : should be delayed until the age of 12-18 months because 
spontaneous canalization occurs in 96% of cases
53
. Probing performed 
within the first 1-2 years of life has a very high success rate. It is 
carried out under general anaesthesia. The rationale is to manually 
overcome the obstructive membrane at the Hasner valve. After 
probing, the lacrimal system is irrigated with saline labelled with 
fluorescein. If fluorescein can be recovered by aspiration from the 
pharynx, successful probing is confirmed. Postoperative steroid 
antibiotic drops are used q.i.d for upto 3 weeks. If no improvement 
repeat probing is done after 6 weeks. Nasal endoscopic monitoring of 
probing is recommended to detect anatomical abnormalities. Results 
are excellent and 90% of children are cured by first probing and a 
further 6% by the second.           
 Lacrimal intubation : if second probing fails then temporary intubation 
with fine silastic tubes with or without balloon dilatation of the 
nasolacrimal duct may effect cure. Success rate of silicone intubation 
as been reported to be from 80 to 90% in congenital nasolacrimal duct 
obstruction 
13,14
.   
 Dacryocystorhinostomy : done very rarely for persistent watering only 
after 3 years of age after completion of bone development. 
22 
 
In children all other causes of watering should be ruled out before 
the diagnosis of congenital dacryocystitis is made. The other causes of 
watering include outflow abnormality and reflex watering. 
Congenital watering
15 
 
 
Outflow abnormality      Reflex watering
 
Punctual agenesis       Congenital glaucoma 
Congenital dacryocystocele    Epiblepharon 
Nasolacrimal duct obstruction     Distichiasis 
Congenital lacrimal-cutaneous fistula 
Acute dacryocystitis 
Acute dacryocystitis is commonly caused by retention of tears 
leading on to secondary infection with bacteria. It is manifested by 
sudden onset pain, erythema and edema over sac area and epiphora. 
Tenderness is localised in the medial canthal area. 
Common organisms causing acute dacryocystitis are 
 Staphylococcus aureus 
 Staphylococcus epidermidis 
 Pseudomonas aeruginosa 
 Klebsiella and acenetobacter 
 Rarely a fungal etiology has also been incriminated 
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Complications include 
 Lacrimal mucocele 
 Lacrimal fistula 
 Lacrimal abscess 
 Chronic conjunctivitis 
 Orbital cellulitis
16
 
 Orbital abscess
16,17
 
Treatment  
This includes institution of appropriate antibiotic therapy 
systemically and locally coupled with warm compresses over the 
inflamed area. Syringing or probing of an acutely inflamed sac is strictly 
contraindicated because of the risk of damage to the inflamed mucosa 
resulting in a fibrotic stricture. If untreated in the early stage, acute 
dacryocystitis may progress to form lacrimal abscess. In such cases, 
surgical drainage is indicated.          
Dacryocystorhinostomy is usually necessary after the acute 
infection has been controlled and should not be delayed because of risk of 
recurrent infection.  
Chronic dacryocystitis 
Presentation is with epiphora which may be associated with 
chronic or recurrent unilateral conjunctivitis. It may be seen as a painless 
swelling at the inner canthus caused by a mucocele.  Sometimes obvious 
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swelling may be absent, although pressure over the sac commonly results 
in reflux mucopurulent material through the canalicular system onto the 
surface of the eye. Chronic dacryocystitis needs to be treated surgically 
prior to any intraocular surgeries. 
A review of literature from Sattler (1885)
30
 to Reddy and Reddy 
(1955)
31
 on bacteriology of dacryocystitis reveals that a good number of 
organisms have been isolated from the sac-fluid. Of these, Streptococcus 
haemolyticus, Bacillus coli, Pneumococcus, Bacillus funduliformis, 
Staphylococcus, Bacillus typhosus, Morax-axenfeld bacillus, Pneumo-
bacillus, Klebs-Loffler bacillus, bacillus Proteus vulgaris, Micrococcus 
catarrhaliis, Bacillus fusiformis, Pfeiffer's bacillus, Friedlander's 
bacillus, Koch's bacillus, Bacillus tetragenes, gram negative bacillus, 
mycotic organisms have been found in pure cultures; the preponderating 
organism being the pneumococcus. These organisms together with 
Staphylococcus have also appeared in mixed infections. While 
Pneumococcus has been isolated in pure cultures in an overwhelming 
majority, in mixed infections the Staphylococcus has been isolated in 
preponderating numbers. 
Prasad B et al
32
 observed bacterial flora in 103 cases of chronic 
dacryocystitis and compared with the flora of 25 normal cases. They 
found a fairly good number of organisms in pure cultures and others in 
mixed state were isolated. Of these organisms, Staphylococcus (all varie-
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ties), Streptococcus (all varieties), Pneumococcus, Diphtheroids, were 
isolated in descending order of frequency. 
Bale RN
33
 did a study of 100 consecutive cases of dacryocystitis, 
of which 43 were bilateral and 57 unilateral (total 143 eyes). It was found 
that the disease was more prevalent in females (57 per cent) than in 
males. The incidence of affection of left and right eyes was equal The 
disease has its commencement at 30 years age and maximum incidence in 
the 5th decade.The common organisms were D pneumonae, Coagulase 
negative Staphylococci, Niesseria catarrhalis, Coagulase positive 
Staphylococci and Klebsiella. Mixed organism infection is not 
uncommon. 
Briscoe D et al,
34
 did a prospective study on changing isolates and 
antibiotic sensitivities of purulent dacryocystitis. The most common 
isolates were Pseudomonas (22%), Staphylococcus (13%), Enterobacter 
(10%), Citrobacter (10%), Streptococcus pneumonia, E.coli and 
Enterococcus (7%). 
Brooke et al (1998),34 reported that both aerobic and anaerobic 
bacteria may cause dacryocystitis. In newborn anaerobic bacteria such as 
Bacteroidecaeae, Fusobacter, Peptostreptococcus and Prevotella cause 
dacryocystitis.  
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Huber Spitzy V et al,
36
 reported Staphylococcus  as the most 
common organism. Also a significant number of gram negative bacilli 
were isolated of which E.coli was the most frequently grown. 
Umesh Bareja et al,
37
 in their study on 114 eyes, in which 57.9% 
constituted gram positive cocci, found that the most effective antibiotic 
was cloxacillin with efficacy of 77%. 
Sun X. et al,
38
 investigated a total of 100 samples obtained from 
lacrimal duct in 91 consecutive patients with chronic dacryocystitis, 
Staphylococcus species represented 34.5% of all strains, followed by 
Corynebacterium diphtheroids (15.5%). The sensitive test revealed 
levofloxacin, ofloxacin and amikacin were the most effective antibiotics.   
Usha kim,
39
 studied 238 samples of dacryocystitis. Positive 
cultures were obtained from 197 samples and no growth in 41 samples. 
Of the positive cultures 124 were of gram positive organism and 93 were 
gram negative. The gram positive organisms were sensitive to 
chloramphenicol (98%),vancomycin (82%) and ofloxacin (75%). The 
gram negative organisms were sensitive to ofloxacin (83%), ciprofloxacin 
(81%), chloramphenicol (65%),gentamicin (60%), tobramycin (57%), 
amikacin(50%). 
MJ Bharathi et al,
40
 studied that the commonest organisms causing 
acute dacryocystitis are Staphylococcus aureus(22.3%) and Pseudomonas 
(16%). In case of chronic dacryocystitis the organisms were 
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Staphylococcus aureus (10.8%) and Streptococcus pneumonia (8.7%)The 
proportions of Staphylococcus aureus and Pseudomonas spp are higher in 
causing acute dacryocystitis, while the proportion of Coagulase negative 
Staphylococcus aureus is higher in chronic dacryocystitis. The 
percentages of antibacterial resistant isolates were higher among bacterial 
species from chronic dacryocystitis. 
Surgical management for NLD obstruction 
The type of surgery depends on the level of obstruction 
 Obstruction at NLD or junction of NLD and sac  -  DCR 
 Obstruction at internal punctum or common canaliculus – DCR with 
silicone tubes 
 Canalicular obstruction at or  beyond 8 mm from the punctum – 
canaliculo  DCR 
 Obstruction less than 8mm from punctum in both canaliculi – 
conjunctivo  DCR 
Dacryocystorhinostomy is of three types 
 Conventional DCR 
 Endonasal DCR 
 Laser assisted DCR ( transcanalicular and endonasal ) 
Conventional DCR 
It involves the anastomosis between the medial wall of the lacrimal 
sac and nasal mucosa through a bony ostium 
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Indications 
 NLD block in adults, chronic dacryocystitis and mucocele 
 NLD block in children not responding to probing and lacrimal 
intubation 
 Partial block in significantly symptomatic patients 
 As part of conjunctivo and canaliculo DCR 
Contraindications 
 Malignancy of lacrimal sac 
 Dry eye syndrome 
 Blood dyscrasias 
 Acute dacryocystitis 
 Children below 3 years 
 Atrophic rhinitis 
 Rhinosporidiosis  
Preoperative work up 
• Hb 
• Urine analysis 
• Bleeding time, clotting time 
• Blood pressure 
• Blood sugar 
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• ENT examination to be done to rule out atrophic rhinitis, turbinate 
hypertrophy, deviated nasal septum, nasal polyps , malignancy 
• Adequate treatment of acute dacryocystitis 
• NSAIDS and anticoagulates should be stopped 3 days prior to surgery 
• Should start instillation of antibiotic eye drops and nasal 
decongestants in ipsilateral nostril twice a day for 3 days prior to 
surgery. Sedatives  may be given to relieve anxiety of the patient    
Nasal packing 
It helps in mucosal decongestion by pressure and vasoconstriction. 
Nasal pack consists of half inch wide and 16 inches long ribbon gauze 
soaked in xylocaine 2% with adrenaline. Naphazoline drops are instilled 
into the nasal cavity. The ipsilateral nasal cavity is packed under direct 
visualization using nasal speculum and packing forceps. 
Surgical technique 
Syringing is done wih methylene blue dye. This stains the sac and 
makes identification of sac easier. Incision is made through the skin 
within, 8 to 10 mm from the medial canthus on the side of the nose, 
starting 2mm above the level of medial canthus  and extending 4mm 
towards the ala of the nose. The skin edges are handled properly and 
dissection is carried down to the periosteum. Direct bone incision can 
also be taken by avoiding damage to angular vessels. Place traction suture 
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with 4.0 silk in each flap. Identify and expose the anterior limb of medial 
palpebral ligament. It maybe cut or just dissected out. 
Expose the periosteum over the anterior lacrimal crest and above it. 
Incise it 3 to 4 mm anterior and parallel to the anterior lacrimal crest. 
Reflect the periosteum from underlying bone and reach upto the anterior 
lacrimal crest. With the blunt end of the lacrimal sac dissector force a 
hole in the thin bone at the junction of lacrimal bone with the frontal 
process of maxilla in the centre or in posterior third of the lacrimal fossa. 
Fracture out a small piece to allow the finest bone punch into the hole and 
gradually enlarge the opening until the whole of lacrimal fossa is 
removed thus exposing the nasal mucosa. Anterior and posterior flaps are 
made in the lacrimal sac and in the nasal mucosa by an H-shaped 
incision. The posterior flaps are sutured together with 1 to 3 interrupted 
5-0 chromic catgut sutures using half circle needle. Similarly the anterior 
flaps are sutured with sufficient tension on the flap to prevent it from 
collapsing. If MPL is incised it should be sutured with 4-0 or 5-0 vicryl. 
Skin is sutured with 5-0 prolene using continuous or interrupted sutures. 
Complications of  DCR 
 Hemorrhage – intranasal bleeding from nasal mucosa requires nasal     
packing for 24 hours. Injection ethamsylate or vitamin K may be given 
 Failed DCR  -  may be due to 
1. Small osteotomy 
31 
 
2. Blockage of anastomosis due to improper suturing, redundant 
flaps, bony fragments, post operative hematoma 
3. Post operative soft tissue infection 
 Sump syndrome 
Management of failed DCR  
 Patients with mucopurulent discharge – repeat DCR with silicone tube 
intubation 
 In case of common canalicular block– canaliculo-DCR with silicone 
tube intubation 
 In case of canalicular block – conjunctivo- DCR 
Endonasal DCR
18,19 
Indications 
 Chronic dacryocystitis with NLD block 
 Mucocele 
Contraindications  
 Lacrimal sac tumours 
 Dacryoliths 
Procedure 
The operation  is performed with the patient under local 
anaesthesia. The nose is packed with a solution containing 2 ml of 1:1000 
epinephrine with xylocaine. The packing is left in the nose for 10 
minutes. A 20- gauge illuminated fibreoptic light probe is passed through 
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the upper or lower canaliculus into the lacrimal sac. The light is located 
endoscopically on the lateral wall of the nose, and its position is noted. A 
1 cm diameter circle of mucosa is removed at the site of transillumination 
to expose the underlying bone. Osteotomy is made using curette, punch, 
chisel, electric burr and lasers. In laser assisted procedures
20
 the laser 
used to make the osteotomy are Holmium YAG and  Argon laser (blue 
green). The lacrimal sac is opened with a 45
○ 
cutting forceps, and the 
opening is enlarged to approximately 1 cm. Metal stents attached to the 
silastic tubing at either end are passed through the upper and lower 
canaliculi . This helps in maintaining patency as the flaps are not 
anastomosed in this procedure.     
Advantages   
 No cutaneous scar 
 Bloodless surgery 
 Speedy recovery 
 Day care procedure 
 Medial canthal anatomy is not disturbed 
 Bilateral DCR can be done in the same sitting  
Disadvantages 
 High cost 
 Steep learning curve 
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 Intranasal manipulations needed at times like inferior turbinate 
fracture or septoplasty 
Canaliculo DCR 
This procedure is done in cases with obstruction of common 
canaliculus. Following skin incision, dissection is carried out till the 
MPL. The  common canaliculus is  freed from the medial canthal tendon 
and all pericanalicular fibrous tissue is excised thoroughly. The most 
medial patent part of common canaliculus is intubated from the punctum 
by two ends of a silicone tube. The common canaliculus is sutured to the 
flaps of the lacrimal sac and DCR completed as usual.  
Very often the sac is also scarred and the patent canalicular 
remnant may be sutured directly to the nasal mucosa. However a 
minimum of 8 mm of the canalicular system must be present to allow this 
anastomosis without undue tension. If less than 8 mm of the canalicular 
system is patent then conjunctivo DCR is considered 
Conjunctiva DCR 
Jones
21
 described a procedure to treat  patients with canalicular 
block by creating an artificial channel between the conjuncival sac and 
the middle meatus . The surgical procedure is the same as in conventional 
DCR until the posterior sac and nasal mucosal flaps are sutured. 
Thereafter the caruncle is resected and a 23 gauge curved hypodermic 
needle is entered in the conjunctiva 2 mm from the canthal angle so as to 
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reach the lacrimal sac. A Lester Jones tube is then advanced through this 
track to reach the lacrimal sac. The anterior flaps and nasal mucosa are 
then sutured together and DCR completed as usual. 
An important aspect in postoperative care is educating the patients 
regarding care of tube and prevention of its extrusion. Extrusions are 
managed by immediate replacement.     
Balloon catheter dilatation 
Becker et al
22
 described this method which is effective in both 
congenital and acquired nasolacrimal duct obstruction. A guide wire is 
passed into the lacrimal sac over which a balloon catheter is guided and 
inflated. This is done twice for 10 minutes. Success rate is around 95% in 
congenital cases and 70% in acquired cases.   
Dacryocystectomy  
DCT was first described by Woolhouse in 1724 as a treatment for 
recurrent dacryocystitis secondary to acquired nasolacrimal duct 
obstruction
23
.
 
However, after the introduction of DCR surgery, the use of 
DCT declined. At present, the main indication for DCT is excision of 
lacrimal sac tumours. However, other less common indications are 
recurrent dacryocystitis due to inflammatory causes such as Wegener's 
granulomatosis when there is a risk of subsequent naso-cutaneous fistula 
formation following DCR surgery
24 
or recurrent dacryocystitis without 
epiphora
25,26
. 
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DCT differs from DCR surgery in that there is no osteotomy or 
breaching of the nasal mucosa and hence there is less risk of aspiration 
pneumonia due to intraoperative nasal haemorrhage
27
. Secondly, DCT is 
a safer procedure to perform on a frail, elderly patient than DCR as the 
surgical time is much shorter than that of external DCR surgery and the 
type of local anaesthesia required is safer in DCT. In DCR surgery under 
local anaesthesia, it is necessary to pack the nose with either cocaine or 
local anaesthetic and nasal decongestant and or vasoconstrictive agent to 
prevent haemorrhage as well as infiltrate the lacrimal fossa with local 
anaesthetic and a vasoconstrictor. These agents can have significant 
systemic effects on frail, elderly patients, with exacerbation of systemic 
hypertension, tachycardia, dysarrhythmia, and a risk of myocardial 
toxicity due to their sympathomimetic action
28,29
. DCT can be performed 
with standard local infiltration of the medial canthal area with lidocaine 
and adrenaline alone without the need for nasal packing. The procedure 
involves identification and excision of the lacrimal sac. 
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MATERIALS AND METHODS 
The study of microbiological profile in chronic dacryocystitis and 
their susceptibility and resistance to antibiotics in South Tamil Nadu was 
carried out in the Department of Ophthalmology,  Tirunelveli Medical 
College, Tirunelveli. 
Settings   :  Ophthalmology ward, microbiological lab                  
Study design :  Single centre observational prospective hospital  
based study 
Period of study :  June 2009 to June 2010 
Ethical approval :  Obtained 
Tirunelveli Medical College Hospital is a tertiary care centre in 
South Tamil Nadu. The patient population is a fairly representative 
sample of  the disease pattern in this region. 
Inclusion Criteria: 
Patients between 16-80 years of age.  
All patients with complaints of mucopurulent discharge, epiphora, 
and sac abscess were included in this study. 
Exclusion Criteria: 
Patients less than 16 years of age. 
Patients with acute dacryocystitis, lacrimal abscess and mucocele 
were excluded from the study. 
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Those who have been treated with systemic or topical antibiotics 
within 1 week of presentation were excluded from the study.  
All cases of pseudoepiphora and epiphora caused by diagnoses 
other than nasolacrimal duct obstruction were also excluded from this 
study. 
Procedure 
Specimens for microbiological analysis were obtained by wiping a 
broth-moistened swab across the lower conjunctival cul-de-sac and also 
from everted punta by applying pressure over the lacrimal sac area. 
Surgically excised lacrimal sacs were collected and were also subjected to 
microbiological analysis. Those cases with mucoid or mucopurulent 
discharge on syringing of the lacrimal sac were advised surgery. In 
patients undergoing dacryocystectomy, a prior ENT clearance was 
obtained and  the sacs were collected intraoperatively and subjected to 
microbiological examination.  
The material obtained was initially inoculated directly onto the 
surface of the solid media such as sheep’s blood agar,chocolate agar, and 
Sabouraud’s dextrose agar and also inoculated into the depth of liquid 
media such as brain heart infusion broth and thioglycollate medium. The 
material obtained was also smeared onto clean, sterile labelled glass 
slides for 10% potassium hydroxide wet mount, Gram stain, Giemsa 
stain, Ziehl-Neelsen acid-fast stain, and Kinyoun’s acid-fast stain. All 
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inoculated media were incubated aerobically. The inoculated Sabouraud’s 
dextrose agar was incubated at 27
◦
C, examined daily, and discarded at 3 
weeks if no growth was seen. The inoculated blood agar, chocolate agar, 
thioglycollate broth, brain–heart infusion broth were incubated at 37
◦
 C, 
examined daily, and discarded at 7 days if growth was not seen. 
Microbial cultures were considered significant if  
 Growth of the same organism was demonstrated on more than one 
solid-phase medium. 
or 
 There was confluent growth at the site of inoculation on one solid 
medium. 
or 
 Growth of one medium was consistent with direct microscopy  
findings (ie, appropriate staining and morphology with Gram stain) 
or 
 The same organism was grown from more than one specimen. 
The specific identification of bacterial isolates were performed 
based on microscopic morphology, staining characteristics, and 
biochemical properties using standard laboratory criteria.13 Standardized 
bacterial inoculums for susceptibility testing was prepared from 4–5 well-
isolated colonies of the same morphological type in 5ml of peptone water. 
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The broth culture was then allowed to incubate at 37
◦
C until a 
slightly visible turbidity appeared (usually 2–5 h), and the turbidity of the 
inoculum was compared with 0.5 Macsarland standard. Standardized 
bacterial inoculum was inoculated on the Mueller–Hinton agar using a 
sterile, non-toxic swab evenly over the entire surface of the agar plate to 
obtain a uniform inoculum. Blood agar was used for  Streptococci and 
other fastidious bacteria. The inoculated plates were then allowed to dry 
for 3–5 min. The antibacterial impregnated discs were applied with a gap 
of 24mm between them and the plates were incubated at 37
◦
C within 15 
min after applying these discs. 
Antibacterial discs (obtained from Hi-media Laboratories Pvt Ltd, 
Mumbai, India) were consistently tested for efficacy against standard 
American Type Culture Collection (ATCC) bacteria (S. aureus ATCC 
25923, S.pneumoniae ATCC 49619, Haemophilus influenzae ATCC 
49241, Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 
25922) as a general quality control laboratory procedure. After 16–18 h 
of incubation, the plates were examined and the diameter of the zones of 
complete inhibition were measured by a ruler. When blood agar was 
tested, the susceptibility was measured by measuring the area where 
haemolysis did not occur.The zone diameter for individual antimicrobial 
agent was translated into sensitivity and resistant categories by referring 
to an interpretative chart as per the recommendation of the NCCLS.  
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The results of the study were compared in respect of their age, sex 
microbiological spectrum, antibiotic sensitivities and interpreted by the 
Students ‘t’ test. S.P.S.S package (13.0) was utilized for the calculations 
of mean , standard deviation and percentages. The P value (P<0.05) was 
considered as significant.   
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OBSERVATION AND RESULTS 
An observational prospective study of the microbiological profile 
in chronic dacryocystitis and their susceptibility and resistance  to 
antibiotics was carried out at Tirunelveli Medical College Hospital. A 
total of 110  eyes of 100 patients were studied in respect of their mean  
age, sex, duration of symptoms, patency of duct, microbiological profile, 
antibiotic susceptibility and treatment procedures. Of the 100 patients  36 
were males and 64 were females. The mean age of presentation of 
chronic dacryocystitis among males was 62.2 + 13.8 whereas that among 
females was 59.5 + 12.8. A total of 200 eyes of 100 patients were 
considered and on syringing 110 had regurgitation of pus, 37 had 
regurgitation of clear fluid and 53 ducts were patent. Of the 110 eyes with 
infection positive culture was obtained from 85 (77.3%) eyes and no 
growth was observed in 25 (22.7%) eyes. A total of 92 (83.6%) eyes 
underwent DCT and 18 (16.4%) eyes underwent DCR. The patients were 
followed up and found to be asymptomatic.   
 
 
 
 
 
 
Percentage distribution of the patients according to their sex
 
Total number 
of patients 
100 
 
 
The percentage distribution of the patients in table 1 reveals that 
the incidence of chronic dacryocystitis is more (64%) among females 
than males (36%).                    
 
                                        
                                         
64%
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Table : 1 
 
Total number of 
male patients 
Total number 
of female patients 
36 64 
 
 
 
36%
male females
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Table : 2 
Age and sex distribution of the patients 
 
Age group 
Male Female Total 
No % No % No % 
30-39 4 11.1 8 12.1 12 12.0 
40-49 2 5.5 2 3.1 4 4.0 
50-59 2 5.6 13 20.3 15 15.0 
60-69 17 47.2 27 42.2 44 44.0 
70-79 7 19.4 11 17.2 18 18.0 
80-89 4 11.1 3 4.7 7 7.0 
Total 36 100.0 64 100.0 100 100.0 
Median (range)       63.5 ( 32- 83 )   62.5 ( 31 – 82 )    63 ( 31 – 83 ) 
Mean + S.D.        62.2 +13.8    59.5 +12.8    60.5 +13.2 
‘t’ value 0. 969          d.f = 98 - 
significance P > 0.05 - 
 
 
The above table describes the median age of males to be 63.5 years 
and that of females 62.5 years. The mean ages of males and females were         
62.2 +13.8 and 59.5 +12.8 years respectively. The difference between the 
mean age of the sexes was not statistically significant ( P > 0.05 ) 
 
                                             
 Comparison of age and sexwise distribution of chronic dacryocystitis
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Table 3 
Comparison of the sexwise distribution of  chronic dacryocystitis 
Duration 
(months) 
Male Female Total 
No % No % No % 
0-10 20 55.5 43 67.2 63 63.0 
10-20 11 30.5 14 21.9 25 25.0 
20-30 2 5.6 4 6.3 6 6.0 
30-40 2 5.6 1 1.5 3 3.0 
40-50 1 2.8 2 3.1 3 3.0 
Total 36 100.0 64 100.0 100 100.0 
Median (range) 8.5 (4 - 46) 8 ( 3 – 42 ) 8 ( 3 – 46 ) 
Mean + S.D. 12.4 +9.9 10.7 +10.7 11.3 +9.0 
‘t’ value 0. 905         d.f = 98 - 
significance P > 0.05 - 
 
The duration of the disease between the two sexes and total 
patients were shown in the above table. The difference between the  mean 
duration of dacryocystitis in males (12.4 +9.9) and females (10.7 +10.7) 
was not statistically significant. It was observed that 63% of patients 
presented within the first 10 months and 25% within the next 10 months. 
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Table : 4  
Laterality of dacryocystitis in males and females 
 
 
Sex Right side Left side Both sides Total 
 Males 12  (33.3%) 7(43.7%) 17(54.8 %) 36 
 Females  24  (66.7%) 9 (56.2%) 31(64.5%) 64 
 Total  36 16 48 100 
 
 
The above table shows the side of involvement of dacryocystitis in 
males and females.  In males right eye was involved in 33.3%, left eye in 
43.7% and both eyes in 54.8%. In females the incidence in right eye is 
66.7%, left eye is 56.2% and both eyes is 64.5%  The total incidence in 
right eye was 36%, incidence in left eye is 16% and involvement of both 
eyes is 48%. 
  
Sexwise comparison of laterality of chronic dacryocystitis
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Table  5 
Percentage distribution of culture positive and culture negative results 
 
Category 
Culture positive 
Culture negative 
(no growth) 
 
Total 
Gram positive 
Total 
Gram negative  
Total Cons Staph Strep Pseudo Kleb E.Coli Hemo 
No. of 
eyes 
32 22 13 67     7   6    2   3 18   25 110 
Percentage 29.1 20.0 11.8 60.9   6.4  5.5   1.8  2.7  16.4  22.7 100 
 
The culture reports of the 110 eyes is shown in the above table. Among the 110 eyes samples from 25 (22.7%) eyes 
showed no growth. The remaining 85 (77.3%) eyes showed growth. Of the 85 eyes gram positive organisms were found in 
67 (60.9%) eyes and gram negative organisms in 18 (16.4%). 32 eyes (29.1%) had Coagulase negative Staphylococcus, 22 
eyes (20.0%) had Staphylococcus aureus, 13 eyes (11.8%) had Streptococcus species,7 eyes (6.4%) had Pseudomonas 
aeruginosa,  6 eyes (5.5%) had Klebsiella species, 2 eyes (1.8%) had Escherichia coli and 3 eyes had Hemophilus species.                              
 Distribution of culture positive and culture negative results
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Surgical treatment of chronic dacryocystitis
Total number of 
patients 
Total number of
110 
 
This table shows the surgical treatment done for those cases which 
had regurgitation of pus on syringing. DCR was done in 18 eyes (16.4%) 
and DCT was done in 92 eyes (83.6%).
 
Surgical treatment of chronic dacryocystitis
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Table 6 
 
 patients 
undergoing DCT 
Total number of patients 
undergoing DCR
92 
 
 
DCR
surgery
 
18 
 
Association between age and surgical procedure done
 
Treatment 
Age of patients
< Median Median +
No. % No.
    DCR   16 88.9   2  
    DCT   33 35.9  59  
    Total    49  44.5  61 
 
The above table shows that the age was associated with the surgical 
procedure done. DCR was done for younger patients and DCT was done 
for older patients. The association was statistically very highly significant 
(P<0.001). 
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0
10
20
30
40
50
60
DCR
52 
Table 7 
 
  
Χ
2    
   
(chi-
square) 
 
d.f. 
 Total 
 % No. % 
11.1   18  100.0  
 
15.05 
 
 
  1 64.1   92 100.0 
55.5  110 100.0 
ical procedure done
DCT
<MEDIAN
>MEDIAN
 
significance 
 
 
  P<0.001 
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Table 8 
Percentage distribution of sensitivity of different antibiotics to organisms 
  
 
 The sensitivity of the drugs to the organisms is shown in the above table. Bacterial isolates showed higher sensitivity 
to Gatifloxacin (84.7%) followed by Cefazolin (80%), Moxifloxacin (76.5%) and Ciprofloxacin (72.9%). Least sensitive 
among the ten drugs was Gentamicin (44.7%).   
 
S.no 
 
Drug 
CoNS 
n=32 
Staph 
n=22 
Strep 
n=13 
Pseudo 
n=7 
Kleb 
n=6 
E.coli 
n=2 
Hemo 
n=3 
Total 
n=85 
No % no % no % no % no % no % no % no % 
1 GA 31 96.9 21 95.6 12 92.3 1 14.3 5 83.3 2 100.0 0 0 72 84.7 
2 M 28 87.5 19 86.4 12 92.3 0 0 5 83.3 1 50.0 0 0 65 76.5 
3 C 27 84.4 18 81.8 10 76.9 1 14.3 5 83.3 1 50.0 0 0 62 72.9 
4 V 23 71.9 15 68.2 10 76.9 1 14.3 3 50.0 0 0 0 0 52 61.2 
5 O 16 50.0 10 45.5 9 69.2 6 85.7 5 83.3 2 100.0 3 100.0 51 60.0 
6 CZ 26 81.3 17 77.3 8 61.5 7 100.0 6 100.0 1 50.0 3 100.0 68 80.0 
7 A 26 81.3 16 72.7 4 30.8 4 57.1 4 66.7 2 100.0 0 0 56 65.9 
8 T 21 65.6 14 63.6 5 38.5 7 100.0 4 66.7 1 50.0 3 100.0 55 64.7 
9 GM 16 50.0 10 45.5 3 23.1 1 14.3 4 66.7 1 50.0 3 100.0 38 44.7 
10 CF 15 46.9 11 50.0 9 69.2 4 57.1 6 100.0 1 50.0 3 100.0 49 57.6 
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Table  9 
Comparison of distribution of percentages of antibiotic sensitivity 
among Gram positive and Gram negative organisms 
 
S.no 
 
Drug 
Gram positive 
n=67 
Gram negative 
n=18  
‘t’ 
 
significance no of 
organism 
% 
no of 
organism 
% 
1 GA 64 95.5 8 44.4 4.265 P<0.001 
2 M 59 88.1 6 33.3 4.647 P<0.001 
3 C 55 82.1 7 38.9 3.481 P<0.001 
4 V 48 71.6 4 22.2 4.359 P<0.001 
5 O 35 52.2 16 88.9 3.825 P<0.001 
6 CZ 51 76.1 17 94.4 2.434 P<0.05 
7 A 46 68.7 10 55.5 1.014 P>0.05 
 
The comparison of sensitivity of antibiotics between gram positive 
and gram negative organisms is shown in the above table. Gram positive 
bacteria were more sensitive to gatifloxacin, moxifloxacin, ciprofloxacin 
and vancomycin. The above sensitivities were statistically very highly 
significant ( P<0.001). The antibiotics such as ofloxacin, cefazolin, 
tobramycin and cefotaxime had more sensitivity with gram negative  than 
gram positive organisms and the sensitivities were statistically significant 
(P<0.05). The antibiotics amikacin and gentamicin had no significant 
sensitivity with either gram positive or gram negative organisms(P>0.05).             
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Table 10 
Analysis of invitro resistance pattern 
 
 
s.no 
 
Drug 
Gram positive  n = 67 Gram negative  n  = 18 
Sensitivity Resistance Intermediate Sensitivity Resistance Intermediate 
No. % No. % No. % No. % No. % No. % 
1 GA 64 95.5   2 3.0    1 1.5   8 44.4  10 55.6   0   0 
2 M 59 88.1   2 3.0    6 8.9   6 33.3  11 61.6   1  5.6 
3 C 55 82.1   4 6.0    8 11.9   7 38.9  11 61.6   0   0  
4 V 48 71.6  16 23.9    3 4.5   4 22.2  14 77.8   0   0  
5 O 35 52.2  21 31.3   11 16.4  16 88.9   2 11.1   0   0 
6 CZ 51 76.1   9 13.4    7 10.5  17 94.4   1 5.6   0   0 
7 A 46 68.7  15 22.4    6 8.9  10 55.5   8 44.4   0   0 
8 T 40 59.7  18 26.9    9 13.4  15 83.3   2 11.1   1  5.6 
9 GM 29 43.3  26 38.8   10 14.9   9 50.0   7 38.9   2 11.1 
10 CF 35 52.2  25 37.3    7 10.5  14 77.8   4 22.2   0    0 
The in vitro resistance analysis is shown in the above table. Gram positive organisms showed high resistance to the 
antibiotics namely gentamicin (38.8%), cefotaxime ( 37.3%), ofloxacin (31.3%), tobramycin (26.9%), vancomycin (23.9%) 
and amikacin (22.4%). Gram negative organisms showed high resistance to the drugs gatifloxacin (55.6%), moxifloxacin 
(61.1%) ciprofloxacin (61.1%) and vancomycin (77.8%) which showed high sensitivity with gram positive organisms.  
 Analysis of invitro resistance in gram positive organisms
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DISCUSSION 
Sex distribution  
The number of male patients in our study was 36 and females 64. 
Thus  there was a female preponderance. 
Duke – Elder
1,41
 states that while the disease in newborn, affects 
both sexes equally, its occurrence among adults is in the ratio of 75-80% - 
females to 25-30% - males. Meller (1929) Ruiz Barranco and Martinez 
Roman (1966) stated that this difference was due to a narrower bony 
nasolacrimal canal in females. 
Heinoven (1920) blamed that the high incidence amongst females 
is due to the fact that females had a higher nasal index. 
Bharathi MJ et al,
40
 in his study found overall female to male ratio 
was 3.9:1 and females (80.9) were more in number than males (19.1)    
The incidence of dacryocystitis in females had been recorded by 
Traquair
41
 as 83 percent by Summer Skill, W. Ft 
43
 as 73 per cent ,       
Sood et al 
44 
 as 63.3 percent and by Bale RN 
33
 as 57 per cent. This is in 
concurrence with our study. 
Age 
In our study the highest incidence is in 60-70 years of life.                  
The mean ages of presentation were 62.2 +13.8 years in males and 
59.5 +12.8 years in females (t =0.969, d.f = 98, p> 0.05) which was 
statistically not significant. 
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 Bale RN 
33
 reports in his study that nearly 78% of cases were over 
the age of 30 years Amongst this the peak was at 51-60 years of age 
(26%). 
Matthew W. et al
45
 reported the mean age of presentation as 60.7 
yrs.   
Bharathi MJ et al
40
 in his study found that patients with age greater 
than 30 years were significantly more in number in chronic dacryocystitis 
(90%) than those aged less than 31 years (10%). 
Laterality 
In our study in males, right eye was involved in 33.3%, left eye in 
43.7% and both eyes in 54.8%. In females the incidence in right eye was 
66.7%, left eye was 56.2% and both eyes was 64.5%  The total incidence 
in right eye was 36%, incidence in left eye was 16% and involvement of 
both eyes was 48%.  
The affection of side was found by Sood et al
44
 as 50 each right and 
left.  Veris
46
 observed the occurrence to be on the left
 
as 66%.   
Bale RN
33
 found that the incidence was 51.04% in left eye  H.Basil 
Jacobs (1959)
47
 in his study found that right side was involved in 53 cases 
left side in 37 cases and 14 cases were bilateral. 
Dalgleish (1967)
48
 stated that there was no significant difference in 
right eye and left eye affection and that the incidence of bilaterality 
increases with age. 
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Thus there is no predilection to any side and it may affect both 
sides equally. 
Duration of symptoms 
It was observed that 63% of patients presented to us within the first 
10 months and 25% within the next 10 months of the onset of symptoms. 
Duct patency 
On syringing of the total 200 eyes, nasolacrimal duct was found to 
be patent in 53 eyes, regurgitation of clear fluid was seen in 37 eyes and 
regurgitation of pus was seen in 110 eyes. Thus the number of eyes with 
infection was 110. 
Bacteriological profile  
The most common gram positive organism cultured in our study 
was  Coagulase negative Staphylococcus (29.1%) followed by 
Staphylococcus aureus (20%) and then Streptococcus (11.8%). 
Similar incidence was reported by Bharathi MJ et al
40
, in cases of 
chronic dacryocystitis, CoNS (563 of 1275; 44.2%) followed by S.aureus 
(138 of 1275; 10.8%) and S. pneumoniae (111 of 1275;8.7%) were found 
to be the predominant bacterial pathogens.  
Das JK et al
49
 report in their study the occurrence of gram positive 
organisms to be 75% which were predominantly Staphylococcus species. 
M.Chaudry et al
50
 found in their study that CoNS constituted 33.96% and 
Staphylococcus aureus 25.46% of gram positive organisms. 
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Streptococcus species represented 20% in our study which is 
higher than Huber Spitzy et al
36
 (2%), Coden et al
51
 (2.3%) and 
Hartikainen et al
52
 (5%). 
In our study Gram negative organisms contributed to 16.4% of all 
isolates. The most frequently isolated species being Pseudomonas 
aeruginosa (7/18; 6.4%) followed by Klebsiella (6/18; 5.5%).  
Similarly Das JK et al
48
 found gram negative organisms to be 25% 
with a predominance of  Pseudomonas aeruginosa. 
Coden DJ et al
50
 observed gram negative organisms in 27% of all 
isolates, including Pseudomonas in 9%. 
Huber Spitzy et al
36
 reported gram negative organisms accounting 
for 26% isolates, the most frequent being E.coli (12%)     
 Surgery 
In our study out of 110 eyes, DCR was done in 18 eyes (16.4%) 
and DCT was done in 92 eyes (83.6%). DCR was done for younger 
patients (less than 40 years of age) and DCT was done for older patients. 
The association was statistically very highly significant (P<0.001). 
Antibiotic Sensitivity 
The analysis of invitro susceptibility showed, that among 
fluoroquinolones, Gatifloxacin (84.7%) and Moxifloxacin (76.5%) shows 
higher efficacy against all pathogens. Gram positive organisms were 
highly sensitive to Gatifloxacin (95.5%) , whereas Gram negative 
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organisms were highly sensitive to Cefazolin (94.4%) .The above 
sensitivities were statistically very highly significant (p<0.001).      
Neither gram positive nor gram negative organisms (p>0.05) had 
significant sensitivity to Amikacin and Gentamicin. 
The analysis of invitro resistance showed that Gram positive 
organisms had high degree of resistance to Gentamicin (38.8%), 
Cefotaxime (37.3%) Ofloxacin (31.3%) and Tobramycin (26.9%).  For 
gram negative organisms Vancomycin (77.8%), Moxifloxacin (61.1%) 
and Ciprofloxacin (61.1%) had highest resistance. Least resistance was 
seen with Cefazolin (5.6%). 
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CONCLUSION 
In our study, incidence of chronic dacryocystitis was found more in 
females than males, the mean age of presentation was 60.5+13.2 years, 
most of the patients presented to us within 10 months of the onset of 
symptoms. DCT was done in 92 eyes and DCR was done 18 eyes. The 
most common micro organism isolated was Coagulase negative 
Staphylococcus followed Staphylococcus aureus & Streptococcus 
species. Gram positive organisms showed highest sensitivity to 
Gatifloxacin , Moxifloxacin  and Gram negative organisms to Cefazolin . 
The high rate of micro-organism positive cultures suggests that adult 
patients should be treated for their lacrimal sac infection before any 
intraocular surgery because of the potential risk of post operative 
infection. Bacterial flora is abundant at the eyelid margin and the setting 
is conducive to a possible spontaneous mutation that can cause antibiotic 
resistance. Hence a prudent use of antibiotics is essential. Unnecessary 
usage of antibiotic leads to emergence of resistance. Thus in cases of 
regurgitation it is better to use Gatifloxacin or Moxifloxacin as they are 
more effective. 
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PROFORMA 
S.No                                        M.R.No.                               Date 
Name 
Age/Sex 
Occupation 
H/o Presenting illness :    Watering 
Discharge  
Pain  
Swelling in sac area 
Duration 
H/o Past  illness          :    Previous similar episodes 
Side involved 
Duration  
Previous surgeries ( DCT/DCR ) 
H/o ENT problems 
H/o Systemic illness 
Ocular examination  
                  Lids      Upper puncta 
Lower puncta 
                 Conjunctiva 
                 Cornea 
                 Anterior chamber 
                 Iris 
                 Pupil 
                 Lens  
                 Extraocular muscles 
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Investigation                                       
Right eye                              left eye  
                ROPLAS 
                Syringing of duct                                                                    
 ENT Opinion  
 
Clinical Diagnosis : 
 
Culture report 
Organism grown in culture: 
Antibiotic more sensitive     : 
 
Treatment planned 
Antibiotic given                  : 
Surgical procedure done   :  
 
Follow up  
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S. 
no 
Op/Ip  
cases 
Age Duration Sex 
Patency Treatment 
Organism 
Grown 
Culture Sensitivity 
RE LE RE LE RE LE G M C V O CZ A T G CF 
1 28752 33 5 M - RP - DCR - Pseudo R R R S R S S S R S 
2 166628 51 6 F RP RC DCT - NO NO - - - - - - - - - - 
3 191830 71 4 F RP RC DCT - CoNS NO S S S S S S S S S S 
4 36380 53 3 F RC RC - - - NO - - - - - - - - - - 
5 36827 62 4 M - RP - DCT - Hemo R R R R S S R S S S 
6 36624 83 16 M RP - DCT - NO - - - - - - - - - - - 
7 206076 54 8 F RC - - - NO - - - - - - - - - - - 
8 38935 61 6 F RP RC DCT _ CoNS - S S S R R I I S S S 
9 38928 63 7 F RC - - - NO - - - - - - - - - - - 
10 41903 34 8 F RC - - - NO - - - - - - - - - - - 
11 223080 65 13 M RP - DCT - Staph - S S S S R S S I S S 
12 43765 55 6 F RC RP - DCT NO Staph S S S S S S S S I S 
13 44723 61 5 F - RP - DCT - Hemo R R R R S S R S S S 
14 44192 34 6 M RP RC DCR - Staph NO S S S R I S S R R I 
15 45735 81 10 M RP RC DCT - Kleb NO S S R R S S S S R S 
16 240481 66 9 M RP RC DCT - CoNS NO S S S S S S S S R R 
17 247806 32 15 F - RP - DCT - ST S S S S S R R R S S 
18 257418 74 8 M - RC - - - NO - - - - - - - - - - 
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19 260212 56 9 F RP - DCT - CoNS - I R S R R S S S R R 
20 272344 52 6 F RP - DCT - ST - S S S S S I R I I S 
21 272307 62 5 M RP - DCT - Staph - S S S R R S I S S S 
22 204914 61 14 F RP - DCT - NO - - - - - - - - - - - 
23 188910 31 9 F - RP - DCR - Pseudo R I R R S S R S S S 
24 121510 61 6 M RP - DCT - CoNS - S S I I R S S S S S 
25 21196 63 5 F - RP - DCT - ST S S S S S S R R R S 
26 94768 63 8 F RP - DCT - Kleb - S S S R S S S S R S 
27 14255 32 4 M RP RC DCR - Staph NO R I S S S S S R R R 
28 36020 65 3 F RC - - - NO - - - - - - - - - - - 
29 30102 64 6 F RP RC DCT - NO NO - - - - - - - - - - 
30 16980 83 8 M RP - DCT - ST - S S S S S R R S R S 
31 12435 53 9 F RP - DCT - Staph - S S I S S R I S S S 
32 15121 72 6 F RP - DCT - CoNS - S S R S S S S S S S 
33 82661 35 14 F RP - DCR - NO - - - - - - - - - - - 
34 12863 73 20 M - RP - DCT - Pseudo R R R R S S S S I S 
35 61161 72 6 M RP RP DCT DCT NO NO - - - - - - - - - - 
36 14021 64 8 F RP RC DCT - CoNS NO S S S S S S S S S S 
37 24327 65 22 M - RP - DCT - Staph S S S R I R R S R R 
38 21062 36 3 F RP RC DCR - CoNS NO S S S S S S S I I I 
39 18442 64 13 M RP - DCT - NO - - - - - - - - - - - 
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40 18045 73 8 F RP - DCT - ST - S S S S S I R I S S 
41 10420 68 6 F RP - DCT - CoNS - S S S R I S S R R R 
42 11130 39 3 F RP RC DCR - CoNS NO S S S S R S S S S S 
43 13028 61 16 M RC RC - - - NO - - - - - - - - - - 
44 11047 67 8 F RP RC DCT - Kleb NO S S S S S S R R S S 
45 12252 73 15 M RP RP DCT DCT NO Staph S I I S R I R S R R 
46 14238 63 6 F RP - DCT - CoNS - S I I S I S S S S R 
47 12220 64 8 F RP - DCT - NO - - - - - - - - - - - 
48 13422 72 3 F RP - DCT - CoNS - S S S R R S S S S S 
49 13542 61 13 M RP - DCT - kleb - S R S S S S S R S S 
50 13719 32 14 F RP RC DCR - NO NO - - - - - - - - - - 
51 20229 82 6 F RP - DCT - CoNS - S I S S S S S S S S 
52 23409 63 5 M RP RP DCT DCT CoNS CoNS S S S S S S S I I R 
53 23167 42 4 M RP - DCR - Staph - S S S S R S S S R R 
54 28481 52 37 M RP RC DCT - CoNS NO S S S S I S S S S S 
55 83812 53 22 F - RP - DCT - Staph S S S S S S S S I I 
56 11388 62 8 M RP RC DCT - NO NO - - - - - - - - - - 
57 11421 33 6 F RP RP DCR DCR CoNS CoNS S S S S S S S S I I 
58 10142 66 18 M RP RC DCT - Staph NO S S S S R S S S S S 
59 13424 71 3 F RP RC DCT - Staph NO S S S S I S S S R R 
60 64221 63 38 M RP - DCT - Pseudo - S R R R S S S S R S 
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61 66336 54 15 F RP RP DCT DCT ST ST S S S S R S S S R R 
62 24271 71 9 M RC RP - DCT NO CoNS S S S S S S S S S S 
63 28831 51 13 F - RP - DCT - CoNS S S S R I I I I I R 
64 23312 77 38 F RP RP DCT DCT Staph Staph S S I R S R R R S S 
65 22441 82 8 F RP RC DCT - Pseudo NO R R S R S S R S I R 
66 20112 62 10 M - RP - DCT - ST S S S S S S I R R S 
67 28382 43 9 F RP - DCR - Staph - S S S S R S S S R R 
68 14402 81 8 F RP - DCT - CoNS - S S I R R R R S S S 
69 13312 61 4 F RP - DCT - CoNS - S S S S S S S R R R 
70 12880 73 16 M RP - DCT - NO - - - - - - - - - - - 
71 42551 64 15 F RP RC DCT - NO - - - - - - - - - - - 
72 42861 65 14 F RP RP DCT DCT NO Staph S S S S R S S S S S 
73 42632 66 6 F RP RC DCT - Staph NO S S S S S S S S S S 
74 21118 74 42 F - RP - DCR CoNS E.Coli S S S R R R S S S R 
75 28743 64 8 M RP RP DCT DCT CoNS NO S I I S I S S S S S 
76 28431 67 13 F RP RP DCT DCT ST ST S S R R I S S S R R 
77 24021 35 15 M RP RC DCR - Staph NO S S S R R S S S S S 
78 14422 61 8 F RC RP - DCT - CoNS S S S S S S S R I I 
79 14851 63 46 M RP RP DCT DCT NO NO - - - - - - - - - - 
80 15631 74 8 F - RP - DCT - Kleb S S S R S S S S S S 
81 15821 61 5 F RP RP DCT DCT NO CoNS S S S S S S S R R R 
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82 15421 62 13 F RP - DCT - Staph - S S S S S S S R R R 
83 14300 63 6 F RP - DCT - Staph - S S S S R S S I R I 
84 12288 54 5 M RP - DCT - E.Coli - S R R R S S S I R S 
85 12431 45 24 F RP RP DCR DCR NO ST R I R S S S R R R S 
86 12348 53 3 F RP RP DCT DCT NO CoNS S S S S R R R S S S 
87 40068 52 15 F - RP - DCT - CoNS S S S S I I I R R R 
88 13246 72 8 M RP RP DCT DCT Staph NO S S S S S S S S S S 
89 14020 72 42 F RP RC DCR - ST NO S S S R S S R R R S 
90 14408 61 16 F RP RP DCT DCT CoNS NO S S S R R I R S S S 
91 13202 52 9 F RP - DCT - Pseudo - R R R R S S R S R R 
92 12082 82 4 M - RP - DCT - CoNS S S S I R S S S S S 
93 11012 75 18 F RP RP DCT DCT CoNS CoNS S S S S S S S R I R 
94 10038 65 6 F RP RP DCT DCT Staph NO S R S I S S S I R R 
95 67321 64 22 F RP - DCT - Kleb - R S S S S S R S S S 
96 43210 67 7 M RP - DCT - CoNS - S S S S R S S S R R 
97 62328 72 4 F RP - DCT - ST - S S S S S R R R S S 
98 20322 61 13 F RP RC DCT - Pseudo NO R R R R S S S S R R 
99 13579 43 8 M RC RP - DCR NO Hemo R R R R S S R S S S 
100 54321 65 24 F RP RC DCT - NO NO - - - - - - - - - - 
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KEY TO MASTER CHART 
RC             -  Regurgitation of clear fluid 
RP             -  Regurgitation of pus 
DCT         -  Dacryocystectomy 
DCR     -  Dacryocystorhinostomy 
CoNS   -  Coagulase Negative Staphylococcus aureus  
Staph   -   Staphylococcus aureus 
ST   - Streptococcus species 
Kleb   - Klebsiella 
Pseudo  -  Pseudomonas 
Hemo   -  Hemophilus 
E.Coli  -  Escherichia coli 
G   -  Gatifloxacin 
M   -  Moxifloxacin 
C   -  Ciprofloxacin 
V   - Vancomycin 
O   -  Ofloxacin 
CZ   -  Cefazolin 
A   - Amikacin 
T   -  Tobramycin 
GM   - Gentamicin 
CF   -  Cefotaxime 
S   - Sensitive 
R   - Resistant 
I   - Intermediate  








